1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow atabecestat: new trials by email Literature Review of atabecestat trials Research Report on atabecestat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia Atabecestat, 5 mg, Atabecestat, 25 mg, Placebo - Asymptomatic Amyloid-positive | Phase 2 / Phase 3 | Terminated | Janssen Research & Development, LLC | 557 | 2015-10-29 | 2025-04-29 |
Alzheimer Disease (1) · Dementia (1)
Janssen Research & Development, LLC (1)
Australia (1) · Belgium (1) · Canada (1) · Denmark (1) · Finland (1) · Germany (1) · Japan (1) · Mexico (1) · Netherlands (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)
2015 (1)